These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 38261629
1. Loss of Airway Phylogenetic Diversity Is Associated with Clinical and Pathobiological Markers of Disease Development in Chronic Obstructive Pulmonary Disease. Opron K, Begley LA, Erb-Downward JR, Li G, Alexis NE, Barjaktarevic I, Barr RG, Bleecker ER, Boucher R, Bowler RP, Christenson SA, Comellas AP, Criner G, Cooper CB, Couper D, Galban CJ, Han MK, Hastie A, Hatt C, Hoffman EA, Kaner RJ, Kesimer M, Krishnan JA, LaFon DC, Martinez FJ, Ortega VE, Peters SP, Paine R, Putcha N, Woodruff PG, Huffnagle GB, Kozik AJ, Curtis JL, Huang YJ, SPIROMICS Investigators. Am J Respir Crit Care Med; 2024 Jul 15; 210(2):186-200. PubMed ID: 38261629 [Abstract] [Full Text] [Related]
2. Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary Disease. Madapoosi SS, Cruickshank-Quinn C, Opron K, Erb-Downward JR, Begley LA, Li G, Barjaktarevic I, Barr RG, Comellas AP, Couper DJ, Cooper CB, Freeman CM, Han MK, Kaner RJ, Labaki W, Martinez FJ, Ortega VE, Peters SP, Paine R, Woodruff P, Curtis JL, Huffnagle GB, Stringer KA, Bowler RP, Esther CR, Reisdorph N, Huang YJ, SPIROMICS Research Group. Am J Respir Crit Care Med; 2022 Aug 15; 206(4):427-439. PubMed ID: 35536732 [Abstract] [Full Text] [Related]
3. Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state. Yang CY, Li SW, Chin CY, Hsu CW, Lee CC, Yeh YM, Wu KA. J Transl Med; 2021 Mar 23; 19(1):121. PubMed ID: 33757530 [Abstract] [Full Text] [Related]
4. Chronic obstructive pulmonary disease upper airway microbiome is associated with select clinical characteristics. Pragman AA, Knutson KA, Gould TJ, Hodgson SW, Isaacson RE, Reilly CS, Wendt CH. PLoS One; 2019 Mar 23; 14(7):e0219962. PubMed ID: 31335912 [Abstract] [Full Text] [Related]
5. Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort. Opron K, Begley LA, Erb-Downward JR, Freeman C, Madapoosi S, Alexis NE, Barjaktarevic I, Graham Barr R, Bleecker ER, Bowler RP, Christenson SA, Comellas AP, Cooper CB, Couper DJ, Doerschuk CM, Dransfield MT, Han MK, Hansel NN, Hastie AT, Hoffman EA, Kaner RJ, Krishnan J, O'Neal WK, Ortega VE, Paine R, Peters SP, Michael Wells J, Woodruff PG, Martinez FJ, Curtis JL, Huffnagle GB, Huang YJ. NPJ Biofilms Microbiomes; 2021 Feb 05; 7(1):14. PubMed ID: 33547327 [Abstract] [Full Text] [Related]
6. Accelerated Lung Function Decline and Mucus-Microbe Evolution in Chronic Obstructive Pulmonary Disease. Meldrum OW, Donaldson GC, Narayana JK, Ivan FX, Jaggi TK, Mac Aogáin M, Finney LJ, Allinson JP, Wedzicha JA, Chotirmall SH. Am J Respir Crit Care Med; 2024 Aug 01; 210(3):298-310. PubMed ID: 38315959 [Abstract] [Full Text] [Related]
7. The Sputum Microbiome in Chronic Obstructive Pulmonary Disease Exacerbations. Huang YJ, Boushey HA. Ann Am Thorac Soc; 2015 Nov 01; 12 Suppl 2(Suppl 2):S176-80. PubMed ID: 26595736 [Abstract] [Full Text] [Related]
8. The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease. Dicker AJ, Huang JTJ, Lonergan M, Keir HR, Fong CJ, Tan B, Cassidy AJ, Finch S, Mullerova H, Miller BE, Tal-Singer R, Chalmers JD. J Allergy Clin Immunol; 2021 Jan 01; 147(1):158-167. PubMed ID: 32353489 [Abstract] [Full Text] [Related]
9. Symptom-related sputum microbiota in stable chronic obstructive pulmonary disease. Diao W, Shen N, Du Y, Erb-Downward JR, Sun X, Guo C, Ke Q, Huffnagle GB, Gyetko MR, He B. Int J Chron Obstruct Pulmon Dis; 2018 Jan 01; 13():2289-2299. PubMed ID: 30104869 [Abstract] [Full Text] [Related]
10. Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease. Huang YJ, Sethi S, Murphy T, Nariya S, Boushey HA, Lynch SV. J Clin Microbiol; 2014 Aug 01; 52(8):2813-23. PubMed ID: 24850358 [Abstract] [Full Text] [Related]
11. The altered sputum microbiome profile in patients with moderate and severe COPD exacerbations, compared to the healthy group in the Indian population. Hazra D, Sm F, Chawla K, Sintchenko V, Martinez E, Magazine R, Siddalingaiah N. F1000Res; 2023 Aug 01; 12():528. PubMed ID: 37928173 [Abstract] [Full Text] [Related]
12. Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study. Pragman AA, Knutson KA, Gould TJ, Isaacson RE, Reilly CS, Wendt CH. Respir Res; 2019 Jun 07; 20(1):114. PubMed ID: 31174538 [Abstract] [Full Text] [Related]
13. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease. Molyneaux PL, Mallia P, Cox MJ, Footitt J, Willis-Owen SA, Homola D, Trujillo-Torralbo MB, Elkin S, Kon OM, Cookson WO, Moffatt MF, Johnston SL. Am J Respir Crit Care Med; 2013 Nov 15; 188(10):1224-31. PubMed ID: 23992479 [Abstract] [Full Text] [Related]
14. Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis. Ramsheh MY, Haldar K, Esteve-Codina A, Purser LF, Richardson M, Müller-Quernheim J, Greulich T, Nowinski A, Barta I, Stendardo M, Boschetto P, Korzybski D, Prasse A, Parr DG, Hohlfeld JM, Döme B, Welte T, Heath S, Gut I, Morrissey JA, Ziegler-Heitbrock L, Barer MR, Singh D, Brightling CE. Lancet Microbe; 2021 Jul 15; 2(7):e300-e310. PubMed ID: 35544166 [Abstract] [Full Text] [Related]
15. Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis. Wang Z, Locantore N, Haldar K, Ramsheh MY, Beech AS, Ma W, Brown JR, Tal-Singer R, Barer MR, Bafadhel M, Donaldson GC, Wedzicha JA, Singh D, Wilkinson TMA, Miller BE, Brightling CE. Am J Respir Crit Care Med; 2021 Jun 15; 203(12):1488-1502. PubMed ID: 33332995 [Abstract] [Full Text] [Related]
16. Airway Mucin 2 Is Decreased in Patients with Severe Chronic Obstructive Pulmonary Disease with Bacterial Colonization. Sibila O, Garcia-Bellmunt L, Giner J, Rodrigo-Troyano A, Suarez-Cuartin G, Torrego A, Castillo D, Solanes I, Mateus EF, Vidal S, Sanchez-Reus F, Sala E, Cosio BG, Restrepo MI, Anzueto A, Chalmers JD, Plaza V. Ann Am Thorac Soc; 2016 May 15; 13(5):636-42. PubMed ID: 26882402 [Abstract] [Full Text] [Related]
17. Sputum Microbiome Is Associated with 1-Year Mortality after Chronic Obstructive Pulmonary Disease Hospitalizations. Leitao Filho FS, Alotaibi NM, Ngan D, Tam S, Yang J, Hollander Z, Chen V, FitzGerald JM, Nislow C, Leung JM, Man SFP, Sin DD. Am J Respir Crit Care Med; 2019 May 15; 199(10):1205-1213. PubMed ID: 30376356 [Abstract] [Full Text] [Related]
18. Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices. Su L, Qiao Y, Luo J, Huang R, Li Z, Zhang H, Zhao H, Wang J, Xiao Y. J Transl Med; 2022 Feb 05; 20(1):76. PubMed ID: 35123490 [Abstract] [Full Text] [Related]
19. Metagenome and Metatranscriptome Profiling of Moderate and Severe COPD Sputum in Taiwanese Han Males. Lee SW, Kuan CS, Wu LS, Weng JT. PLoS One; 2016 Feb 05; 11(7):e0159066. PubMed ID: 27428540 [Abstract] [Full Text] [Related]
20. Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort. Radicioni G, Ceppe A, Ford AA, Alexis NE, Barr RG, Bleecker ER, Christenson SA, Cooper CB, Han MK, Hansel NN, Hastie AT, Hoffman EA, Kanner RE, Martinez FJ, Ozkan E, Paine R, Woodruff PG, O'Neal WK, Boucher RC, Kesimer M. Lancet Respir Med; 2021 Nov 05; 9(11):1241-1254. PubMed ID: 34058148 [Abstract] [Full Text] [Related] Page: [Next] [New Search]